Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia;Prevenção de fibrilação atrial com amiodarona em moderada dosagem no pós-operatório de cirurgia cardíaca é segura e eficaz em pacientes de alto risco para desenvolver essa arritmia

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 1, 2007, Pages

  Alves, Renato Jorge ^a,b   Geovanini, Glaucylara Reis ^a   De Brito, Gisele ^a   Miguel, Gabriel A S ^a   Glauser, Valéria A ^a   Nakiri, Kenji ^a  

^a Hospital Santa Cruz   (Brazil)

^b Unidade Coronariana   (Brazil)

Author keywords

Amiodarone; Atrial fibrillation therapy; Postoperative care; Thoracic surgery

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART SURGERY; HEART VALVE SURGERY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; AGED; DRUG EFFECT; EPIDEMIOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION;

AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; ELECTROCARDIOGRAPHY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD;

EID: 34548706041     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Costa R, Costa SPL, Peres AK, Seixas TN. Prevention of atrial fibrillation after cardiac surgery. REBLAMPA. 2003;16(2):87-92.
2. Leitch JW, Thomsom D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary bypass grafting. J Thorac Cardiovasc Surg. 1990;100:338-42.
3. Hashimoto K, Listrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after bypass. J Thorac Cardiovasc Surg. 1991;101:56-65.
4. Janusz S, Rogowski J, Anisimowiscz L, Lango R, Narkiewicz M. Atrial fibrillation after coronary artery bypass grafting without cardiopulmonary bypass. Eur J Cardio-Thorac Surg. 2000;17:520-3.
5. Reed GL, Singer DE, Picard EH, DeSanctis RW. Stroke following coronary-artery bypass surgery: a case control estimate of the risk from carotid bruits. N Engl J Med. 1988;319:246-50.
6. Fuller JA, Adams GG, Buxton AE. Atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1990;98:821-5.
7. Yousif H, Davies G, Oakley CM. Peri-operative supraventricular arrhythmias in coronary surgery. Int J Cardiol. 1990;26:313-8.
8. Piegas LS, Gun C. Fibrilação atrial no pós- operatório de revascularização miocárdica. Rev Soc Cardiol Estado de São Paulo. 1994;4:305-11.
9. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135:1061-73.
10. Hogue CW Jr, Domitrovich PP, Stein PK, Despotis GD, Re L, Schuessler RB, et al. RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft surgery. Circulation. 1998;98(5):429-34.
11. Zaman AG, Archhold RA, Helft G, Paul EA, Curzen NP, Mills PG. Circulation. 2000;101(12):1403-8.
12. Mathew JP, Parks R, Savino JS, Friedman AS, Koch C, Mangano DT, et al. Atrial fibrillation following coronary artery bypass graft surgery. JAMA. 1996;276:300-6.
13. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery. Circulation. 2002;106:75-80.
14. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation. 1996;94:390-7.
15. Frost L, Molgaard H, Christiansen EH, Hjortholm K, Paulsen PK, Thomsen PEB. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Int J Cardiol. 1992;36:253-61.
16. Rubin DA, Nieminski KE, Reed GE, Herman MV. Predictors, prevention and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg. 1987;94:331-5.
17. Mendes LA, Connelly GP, McKenney PA, Podrid PJ, Cupples LA, Shemin RJ, et al. Right coronary artery stenosis: an independent predictor of atrial fibrillation after coronary artery bypass surgery. J Am Coll Cardiol. 1995;25(1):198-202.
18. Alcalde RV, Guaragna JC, Bodanese LC, Castro I, Sussenbach E, Noer R, et al. Alta dose de amiodarona em curto período reduz incidência de fibrilação atrial no pós-operatório de cirurgia de revascularização miocárdica. Arq Bras Cardiol. 2006;87(3):236-40.
19. Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The Amiodarone Reduction in Coronary Heart (ARCH) Trial. J Am Coll Cardiol. 1999;34:343-7.
20. Redle JD, Khurana S, Marzan R, McCullough PA, Stewart JR, Westveer DC, et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J. 1999;138:144-50.
21. Auer J, Weber T, Berent R, Puschmann R, Hartl P, Ng CK, et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J. 2004;147(4):636-43.
22. Coleman CI, Perkerson KA, Gillespie EL, Kluger J, Gallagher R, Horowitz S, et al. Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother. 2004;38(12):2012-6.
23. Mahoney EM, Thompson TD, Veledar E, Williams J, Weintraub WS. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol. 2002;40(4):737-45.
24. Kerstein J, Soodan A, Qamar M, Majid M, Lichstein E, Hollander G, et al. Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary bypass surgery: the GAP study. Chest. 2004;126:716-24.